SOLICITATION NOTICE
A -- Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA1/TA2
- Notice Date
- 5/27/2026 2:47:30 PM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- DEF ADVANCED RESEARCH PROJECTS AGCY ARLINGTON VA 222032114 USA
- ZIP Code
- 222032114
- Solicitation Number
- DARPA-PS-26-124
- Response Due
- 6/24/2026 4:00:00 PM
- Archive Date
- 07/24/2026
- Point of Contact
- BAA Coordinator
- E-Mail Address
-
RAPIID@darpa.mil
(RAPIID@darpa.mil)
- Description
- The Resuscitation and Prevention of Ischemia-induced Dysfunction (RAPIID) program seeks to deliver a transformative, end-to-end resuscitation system that redefines far-forward trauma care. RAPIID aims for this system to be fieldable, usable, and scalable, providing a capability equivalent or superior to stored whole blood in early resuscitation while removing dependence on cold chain and donor logistics. RAPIID seeks to do this by developing a blood analog system (BAS) comprising sequentially administered blood analog components, integrated with ruggedized delivery formats, point-of-care diagnostics, and clinical practice guidelines (CPGs). To maximize post-program viability of developed products, RAPIID will develop and execute effective regulatory and commercialization strategies and accelerate advanced development through technology readiness level (TRL) 7 (Scale-up and Phase II Clinical Trials)1 for blood analog components and TRL 8 (Clinical Studies)2 for devices and diagnostics. This solicitation is to request proposals addressing ONLY Phase 1 of Task Area (TA)-1 and/or TA-2.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/0cc7aef506074243baab86c4f451dfe2/view)
- Record
- SN07830091-F 20260529/260527230045 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |